There was no evidence of association between this variant and breast cancer risk in BRCA1 mutation carriers or between the same variant and ovarian cancer risk in either BRCA1 or BRCA2 mutation carriers (p > 0.30). This evidence concerns the gene BRCA2 and ovarian cancer.